Lower-middle income (World Bank) vs Uzbekistan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Lower-middle income (World Bank)
81.0%
in 2025
Uzbekistan
99.0%
in 2025
Lower-middle income (World Bank) rank
4th
Uzbekistan rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Lower-middle income (World Bank)
- Uzbekistan
How they compare
Uzbekistan currently reports 99.0% against 81.0% in Lower-middle income (World Bank), a difference of 18.0%.
That makes Uzbekistan's figure about 1.2 times Lower-middle income (World Bank)'s.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Uzbekistan ahead.
Lower-middle income (World Bank) ranks 4th and Uzbekistan ranks 1st of 11 groups.
Uzbekistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 24.9% | 29.4% | 4.5% | Uzbekistan |
| 2020s | 68.0% | 97.0% | 29.0% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Lower-middle income (World Bank) or Uzbekistan?
- Uzbekistan, at 99.0% against 81.0% in Lower-middle income (World Bank) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Lower-middle income (World Bank) and Uzbekistan?
- 18.0%, with Uzbekistan ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Uzbekistan?
- 18 years are reported by both, from 2008 to 2025.
- How do Lower-middle income (World Bank) and Uzbekistan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Lower-middle income (World Bank) ranks 4th and Uzbekistan ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.